J‐M. Herbert
Sanofi (France)(FR)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Platelet Disorders and Treatments, Heparin-Induced Thrombocytopenia and Thrombosis, Coronary Interventions and Diagnostics, Cardiac electrophysiology and arrhythmias
Most-Cited Works
- → Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure(1999)797 cited
- → Cross-reactivity of human molecular markers for detection of prethrombotic states in various animal species(1995)84 cited
- → Hirudin ameliorates intestinal radiation toxicity in the rat: support for thrombin inhibition as strategy to minimize side‐effects after radiation therapy and as countermeasure against radiation exposure(2004)58 cited
- → Antithrombotic Properties of SSR182289A, a New, Orally Active Thrombin Inhibitor(2003)22 cited
- → Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivo(2003)14 cited
- → Comparative effects of two synthetic oligosaccharides on platelet activation induced by plasma from HIT patients(2003)6 cited
- → SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis(2004)3 cited
- → Paradoxical increase of plaque growth and collagen deposition in atherosclerotic mice lacking plasminogen activator inhibitor-1 (PAI-1)(2000)